Welcome to the Rando Laboratory
Funding for the research comes from the Glenn Foundation for Medical Research , the NIH (NIA, NIAMS, and NINDS), the Department of Veterans Affairs, the Muscular Dystrophy Association, the American Federation for Aging Research and the Duchenne Parent Project (Netherlands).
Stem cells express genes differently in the lab dish than in the body
The Stanford research suggests that any conclusions about stem cell function based on studies of stem cells in lab dishes may now need to be reconsidered in light of the fact that the cells’ biology changes during isolation.
Clinical trial finds blood-plasma infusions for Alzheimer’s safe, promising
In a small safety trial based on preclinical work by a Stanford researcher, participants receiving blood plasma infusions from young donors showed some evidence of improvement.
Infusions of young blood tested in patients with dementia
The first controlled, but controversial and small, clinical trial of giving young blood to people with dementia has reported that the procedure appears safe. It has also hinted that it may even produce modest improvements in the daily lives of people who have Alzheimer’s disease.
Is aging a disease that can be cured?
The oldest person that we know of lived to be 122 years old. Is that the limit? Is aging a disease that can be conquered and reversed? Scientists think it may be possible – and sooner than we think. At a gathering at The New Yorker’s TechFest in early October, Bill Maris, a venture capitalist involved in aging research, and Thomas Rando, a professor of neurology at Stanford University acknowledged that the study of aging is a tricky business – and it’s relatively new.